Aknamed

Gurugram, India Founded: 2018 • Age: 8 yrs Minicorn Acquired By API Holdings
Cloud and AI-based material management software for hospitals is offered.

About Aknamed

Aknamed is a Healthcare company based in Gurugram (India) founded in 2018 by Saurabh Pandey, Mahadevan Narayanamoni, Shaunak Joshi, and Mayank Kapoor, and was acquired by API Holdings in September 2021. Cloud and AI-based material management software for hospitals is offered. Aknamed has raised $21.85 million across 5 funding rounds from investors including API Holdings, Lightrock and LGT Lightstone. The company has 175 employees. Aknamed has completed 1 acquisition, including Vardhman Health. Aknamed was last valued at $66.01 million in May 2021. Its chief executive, as recorded, is Saurabh Pandey. Its Indian entity Akna Medical Private Limited reported revenue of β‚Ή900 Cr. Aknamed offers products and services including SmartBuy and SmartChain. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions.

Company details

Aknamed was founded in 2018 in Gurugram, India, within the healthcare technology sector. Material management software is provided for hospitals through cloud and AI platforms. Purchase and consumption data are analyzed via machine learning tools in the Smart Buy suite. Products are tracked digitally using barcodes across their lifecycle, with automated capture of details like batch numbers and expiry dates. Operations focus on streamlining hospital inventory processes.

  • Headquarters Gurugram, India
  • Employees 175
  • Founders Saurabh Pandey, Mahadevan Narayanamoni, Shaunak Joshi, Mayank Kapoor
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aknamed.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by API Holdings (Sep 2021)
  • Legal Name Akna Medical Private Limited
  • Date of Incorporation 08 May, 2018
  • Jurisdiction Thane, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹900 Cr

    FY 2025 · -7% YoY

  • Net Loss
    -₹257 Cr

    FY 2025 · -29% margin

  • EBITDA
    -₹175 Cr

    FY 2025 · -19% margin

  • Total Equity Funding
    $21.85M (USD)

    in 5 rounds

  • Investors
  • Employee Count
    175
  • Investments & Acquisitions
  • Acquired by
    API Holdings

    (Sep 2021)

Products & Services of Aknamed

Aknamed offers a comprehensive portfolio of products and services, including SmartBuy and SmartChain.

SmartBuy
Procurement Platform

Platform for optimizing hospital procurement and inventory management.

SmartChain
Supply Chain Management

System for tracking and consolidating hospital supply chains efficiently.

Funding Insights of Aknamed

Aknamed has successfully raised a total of $21.85M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $21.85M
  • Total Rounds 5
  • First Round $430,736

    (May 2019)

  • Investors Count 16

All 5 funding rounds of Aknamed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2025Debt – Venture––
May 2021$5.05MSeries A$66.01MLightrock, LGT Lightstone
–
Nov 2020$9.31MSeries A$58.56MLightrock, LGT Lightstone
Mar 2020$7.06MSeries A$β€’β€’β€’β€’β€’Lightrock, LGT Lightstone
–
May 2019$430,736Seed$β€’β€’β€’β€’β€’Hiten Pravin Shah, Tejas Subramanium
Valuation history
DateValuationStage
May 2021$66.01Mβ€’β€’β€’β€’β€’β€’β€’β€’
Nov 2020$58.56Mβ€’β€’β€’β€’β€’β€’β€’β€’
Mar 2020$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
May 2019$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Aknamed

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $66.01M (May 2021). 17 investors in total: 6 institutional and 11 angel.

Investors in Aknamed

Aknamed has secured backing from 17 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include API Holdings, Lightrock and LGT Lightstone.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investments are directed toward growth-stage companies generating scalable impact.
2009lightrock.comLondon, United Kingdom
Venture capital firm focused on multiple sectors
telamainvestments.tcc.modeBengaluru, India
strideventures.global
lgtlightstone.com
Digital healthcare tools are offered for pharmacies and clinics management.
2012apiholdings.inMumbai, India

Vrinda Mathur

unknown_8731a74b70a24290a

Apurva Shah

Co-founder of Vahan.ai, active angel investor in Indian startups
unknown_21af1dfce50a4a3bb

Saurabh Pandey

Angel investor and entrepreneur, focused on tech startups in India.
unknown_a36431582ee149aea

Mahad Narayanamoni

unknown_722591ab724242108

Mayank Kapoor

Angel investor and entrepreneur, focusing on early-stage Indian startups.
unknown_2f4bb94c4d8f40bf9
Premium access

Investor details for Aknamed

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Akna Medical Private Limited (Aknamed)

Akna Medical Private Limited is the primary company behind Aknamed. The boards of the 2 registered companies of Aknamed currently have 6 directors; the longest-serving is Ish Sadana, appointed in 2022. 24 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ish Sadana
DIN 07141836
Director11 Feb 20224 yrs 8 moAkna Medical Private Limited, Shreeji Distributors Pharma Private Limited
Kalpana Srinivasan
DIN 00008178
Director04 Mar 20224 yrs 7 moAkna Medical Private Limited, Shreeji Distributors Pharma Private Limited
Ashish Arora
DIN 08903038
Additional Director05 Feb 20251 yr 8 moShreeji Distributors Pharma Private Limited
Gaurav Dadu
DIN 10939365
CFO12 Mar 20251 yr 7 moAkna Medical Private Limited
Shravan Kumar Reddy Darmareddy
DIN 11220373
Whole-Time Director30 Jul 20251 yr 2 moShreeji Distributors Pharma Private Limited
Uday Patel Kadam
DIN 09277168
Additional Director12 Nov 202511 moAkna Medical Private Limited, Shreeji Distributors Pharma Private Limited

People of Aknamed

4 people are tracked at Aknamed (4 in leadership); the tracked headcount is 175.

NameRoleGroup
Co-Founder & CEOLeadership
Mahadevan Narayanamoni
Co-Founder & ChairmanLeadership
Shaunak Joshi
Co-FounderLeadership
Co-Founder & COOLeadership
Premium access

Complete people profiles for Aknamed

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Aknamed

Figures of Akna Medical Private Limited, the primary company behind Aknamed, for FY 2025. Revenue was ₹900 Cr (-7% year on year). Net loss was -₹257 Cr (-29% margin). EBITDA was -₹175 Cr (-19% margin). Revenue has grown at a compounded annual rate of +1% over three years and +107% over five years.

  • ₹900 CrRevenue · FY 2025 · -7% YoY
  • -₹257 CrNet loss · -29% margin
  • -₹175 CrEBITDA · -19% margin
  • ₹3.35 CrPaid-up capital
  • 175Employees (provident fund records)
  • +1%Revenue CAGR, 3 years
  • +107%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Akna Medical Private Limited are on its company page.

Premium access

Detailed financial statements for Aknamed

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aknamed

Aknamed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vardhman Health.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Manufacturer of tablets, capsules, syrup, and injectables
vardhmanhealth.comBengaluru, India1988May 2021$40M
Premium access

Complete acquisition details for Aknamed

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Aknamed

6 dated milestones of Aknamed across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aknamed is founded.
  2. Funding First funding round of $431K.
  3. Milestone Reaches Minicorn status.
  4. Acquisition Acquires Vardhman Health.
  5. Exit Acquired by API Holdings.
  6. Funding Latest funding round, Debt – Venture,.

Web traffic of Aknamed

The website of Aknamed (aknamed.com) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 46.3% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aknamed

Premium access

Complete news archive for Aknamed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aknamed

Aknamed was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Aknamed is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

Saurabh Pandey is the CEO of Aknamed, as recorded in our data. They have also founded this company.

Aknamed is a funded company, having raised a total of $21.85M across 5 funding rounds to date. The company's 1st funding round was a Seed of $430.74K, raised on May 2019.

Aknamed has 175 employees.

The primary company behind Aknamed, Akna Medical Private Limited, reported revenue of β‚Ή900 Cr for FY 2025, down 7% year on year.

Aknamed was founded in 2018 in Gurugram, India, within the healthcare technology sector. Material management software is provided for hospitals through cloud and AI platforms. Purchase and consumption data are analyzed via machine learning tools in the Smart Buy suite. Products are tracked digitally using barcodes across their lifecycle, with automated capture of details like batch numbers and expiry dates. Operations focus on streamlining hospital inventory processes.

Aknamed offers SmartBuy and SmartChain.

Aknamed has made 1 acquisition, including Vardhman Health.

Aknamed has 17 investors. Key investors include API Holdings, Lightrock, LGT Lightstone, Vrinda Mathur, and Apurva Shah.

The valuation of Aknamed is $66.01M as of May 2021.

Aknamed is associated with 2 legal entities: Akna Medical Private Limited, Shreeji Distributors Pharma Private Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available